China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference
 Tuesday, January 9, 2018

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company will participate in the 36th Annual J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis Hotel in San Francisco, California, from January 8-11, 2018. The management will meet with investors at the event.

For additional information or to request a meeting with management, please contact your J.P. Morgan institutional sales representative.